< Back | |
17 Jun 2015 | |
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Gemifloxacin Mesylate Tablets (320 mg) with 180 days of generic drug exclusivity. | |
View all announcements for ORCHID CHEMICALS & PHARMACEUTICALS LTD. | Source: BSE India |